← Browse by Condition
Medical Condition
small cell lung cancer
Total Trials
16
Recruiting Now
16
Trial Phases
Phase 4, Phase 1, Phase 2, Phase 2
NCT04342429
Recruiting
Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer
Enrollment
30 pts
Location
United States
Sponsor
Emory University
NCT07026669
Recruiting
A Multi-omics Sequencing-based Model for Predicting Efficacy and Dynamic Monitoring of Treatment in Small Cell Lung Cancer
Enrollment
40 pts
Location
China
Sponsor
Cancer Institute and Hospital,...
NCT06467786 Phase 4
Recruiting
Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer
Enrollment
24 pts
Location
China
Sponsor
Tang-Du Hospital
NCT06047379 Phase 1, Phase 2
Recruiting
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Enrollment
134 pts
Location
United States
Sponsor
Neonc Technologies, Inc.
NCT07155174 Phase 2
Recruiting
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
Enrollment
180 pts
Location
United States, Israe...
Sponsor
AbbVie
NCT02146170
Recruiting
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
Enrollment
2,000 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT07174583 Phase 1, Phase 2
Recruiting
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
Enrollment
208 pts
Location
United States, Austr...
Sponsor
IDEAYA Biosciences
NCT04539977 Phase 2
Recruiting
PD-L1 Antibody (TQB2450) Plus Chemotherapy for Previously Untreated Limited- Stage Small-cell Lung Cancer
Enrollment
40 pts
Location
China
Sponsor
Shanghai Pulmonary Hospital, S...
NCT06498479 Phase 3
Recruiting
ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer
Enrollment
460 pts
Location
China
Sponsor
Hansoh BioMedical R&D Company
NCT06103682
Recruiting
LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)
Enrollment
100 pts
Location
United States
Sponsor
University of California, Davi...
NCT07155200 Phase 1, Phase 2
Recruiting
Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)
Enrollment
42 pts
Location
United States
Sponsor
Washington University School o...
NCT06527898 Phase 1, Phase 2
Recruiting
Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer
Enrollment
45 pts
Location
China
Sponsor
Anhui Provincial Hospital
NCT06486428
Recruiting
Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
Enrollment
30 pts
Location
United States
Sponsor
Addario Lung Cancer Medical In...
NCT05623956
Recruiting
Proteomics in Small Cell Lung Cancer
Enrollment
50 pts
Location
Denmark
Sponsor
Aalborg University Hospital
NCT06970795 Phase 1
Recruiting
A Study of SYS6040 for Injection in Patients With Advanced Solid Tumors
Enrollment
180 pts
Location
China
Sponsor
CSPC Megalith Biopharmaceutica...
NCT04585750 Phase 1, Phase 2
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Enrollment
300 pts
Location
United States, Austr...
Sponsor
PMV Pharmaceuticals, Inc